Bank of America’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.6M Buy
1,101,509
+154,659
+16% +$6.68M ﹤0.01% 1543
2025
Q1
$32.7M Buy
946,850
+511,899
+118% +$17.7M ﹤0.01% 1719
2024
Q4
$11.9M Sell
434,951
-43,522
-9% -$1.19M ﹤0.01% 2353
2024
Q3
$12.2M Sell
478,473
-164,787
-26% -$4.2M ﹤0.01% 2478
2024
Q2
$16.3M Sell
643,260
-174,482
-21% -$4.42M ﹤0.01% 2148
2024
Q1
$25.3M Buy
817,742
+393,504
+93% +$12.2M ﹤0.01% 1781
2023
Q4
$17.1M Sell
424,238
-324,859
-43% -$13.1M ﹤0.01% 1948
2023
Q3
$19.8M Buy
749,097
+24,389
+3% +$643K ﹤0.01% 1749
2023
Q2
$12.5M Sell
724,708
-640,349
-47% -$11M ﹤0.01% 2121
2023
Q1
$22.6M Buy
1,365,057
+519,245
+61% +$8.61M ﹤0.01% 1738
2022
Q4
$6.45M Buy
845,812
+310,483
+58% +$2.37M ﹤0.01% 2679
2022
Q3
$5.32M Sell
535,329
-24,602
-4% -$245K ﹤0.01% 2786
2022
Q2
$5.08M Sell
559,931
-576,140
-51% -$5.23M ﹤0.01% 2909
2022
Q1
$11.5M Buy
1,136,071
+512,411
+82% +$5.2M ﹤0.01% 2364
2021
Q4
$10.4M Buy
623,660
+135,616
+28% +$2.26M ﹤0.01% 2477
2021
Q3
$22.9M Sell
488,044
-54,393
-10% -$2.55M ﹤0.01% 1793
2021
Q2
$33.1M Buy
542,437
+322,167
+146% +$19.6M ﹤0.01% 1498
2021
Q1
$13.6M Buy
220,270
+153,610
+230% +$9.46M ﹤0.01% 2158
2020
Q4
$4.74M Buy
66,660
+29,832
+81% +$2.12M ﹤0.01% 2749
2020
Q3
$1.38M Buy
36,828
+14,748
+67% +$553K ﹤0.01% 3470
2020
Q2
$720K Buy
22,080
+1,621
+8% +$52.9K ﹤0.01% 3886
2020
Q1
$594K Sell
20,459
-19,494
-49% -$566K ﹤0.01% 3890
2019
Q4
$1.4M Buy
39,953
+35,086
+721% +$1.23M ﹤0.01% 3655
2019
Q3
$104K Buy
+4,867
New +$104K ﹤0.01% 5212